Garret Yount, Ph.D.
SETH group founder previous research, documented the potent effects of CBD and THC on gioblastoma brain cancer tissue cultures showing them to be selectively effective at killing cancer cells while leaving healthy cells unharmed.
Yount’s latest research project aims to repeat his previous results and expand upon them using a standardized whole plant extract derived from cannabis that is rich in CBD and natural terpenes. He hopes to repeat his previous results and, using advanced next-generation genome sequencing technology, reveal for the first time the underlying cellular mechanisms responsible for the observed effects.
He expects to find that cannabinoids derived from a whole plant extract are effective at selectively inducing a process called apoptosis which is a naturally occurring process of programmed cell death. This is considered the holy grail for cancer researchers because apoptosis is not associated with harmful inflammation because the process degrades and recycles the cellular machinery before dying.
The SETH group is currently raising money through it’s new website at www.thesethgroup.org and through their facbook page.
They’ll soon be launching a crowdfunding campaign which they hope will raise sufficient funds to pay for the research and raise awareness about the therapeutic use of cannabis in cancer treatment.